EDWARD GRAVISS to Heart Failure
This is a "connection" page, showing publications EDWARD GRAVISS has written about Heart Failure.
Connection Strength
0.539
-
Relation of Left Ventricular Diastolic Function to Global Fibrosis Burden: Implications for Heart Failure Risk Stratification. JACC Cardiovasc Imaging. 2023 06; 16(6):783-796.
Score: 0.085
-
Tissue plasminogen activator in left ventricular assist device-related intravascular hemolysis after failed augmented anticoagulation. Int J Artif Organs. 2022 Nov; 45(11):911-918.
Score: 0.082
-
A multi-institutional retrospective analysis on impact of RV acute mechanical support timing after LVAD implantation on 1-year mortality and predictors of RV acute mechanical support weaning. J Heart Lung Transplant. 2022 02; 41(2):244-254.
Score: 0.078
-
Examining the Relationship and Prognostic Implication of Diabetic Status and Extracellular Matrix Expansion by Cardiac Magnetic Resonance. Circ Cardiovasc Imaging. 2020 07; 13(7):e011000.
Score: 0.071
-
Relationship of extracellular volume assessed on cardiac magnetic resonance and serum cardiac troponins and natriuretic peptides with heart failure outcomes. Sci Rep. 2019 12 27; 9(1):20168.
Score: 0.068
-
Risk Stratification of Patients With Current Generation Continuous-Flow Left Ventricular Assist Devices Being Bridged to Heart Transplantation. ASAIO J. 2018 Mar/Apr; 64(2):196-202.
Score: 0.060
-
In-hospital use of non-steroidal anti-inflammatory drugs in patients with?heart failure in academic centers in?the?United States. Int J Risk Saf Med. 2016; 28(4):181-188.
Score: 0.052
-
Impact of statins on incidence of gastrointestinal bleeding events among patients with continuous-flow left ventricular assist devices. Int J Artif Organs. 2024 Nov; 47(11):826-835.
Score: 0.024
-
Endothelial Dysfunction-related Neurological Bleeds with Continuous Flow-Left Ventricular Assist Devices Measured by Digital Thermal Monitor. ASAIO J. 2021 05 01; 67(5):561-566.
Score: 0.019